Related Experiment Video
Updated: Mar 7, 2026

Method of Studying Palatal Fusion using Static Organ Culture
Published on: September 19, 2015
Prevalence of 22q11.2 microdeletion syndrome in Iranian patients with cleft palate
Narges Nouri1, Mehrdad Memarzadeh2, Mansoor Salehi3
1Isfahan Cleft Lip and Palate Clinic, Faculty of Rehabilitation, Isfahan University of Medical Sciences, Isfahan, Iran; Department of Genetics and Molecular Biology, Medical School, Isfahan University of Medical Sciences, Isfahan, Iran.
Insights
22q11.2 microdeletion syndrome, a common genetic disorder, was found in 3.97% of Iranian infants with palatal anomalies. Submucous cleft palate or velopharyngeal incompetence combined with developmental delay may indicate the need for genetic testing.
Area of Science:
- Genetics
- Pediatrics
- Medical Diagnostics
Background:
- 22q11.2 microdeletion syndrome is a frequent genetic disorder linked to developmental issues, immune problems, and cleft palate.
- Early diagnosis and treatment are crucial for managing this condition.
- Identifying effective screening criteria for infants is essential.
Purpose of the Study:
- To determine the prevalence of 22q11.2 deletion syndrome in Iranian infants with palatal anomalies.
- To explore potential screening criteria for early identification of 22q11.2 deletion syndrome.
Main Methods:
- A 5-year study involving 378 Iranian patients with palatal anomalies.
- Patients included those with cleft palate only (CPO) and those with velopharyngeal incompetence (VPI) and/or submucous cleft palate (SMCP).
- DNA copy number analysis was performed using multiplex ligation-dependent probe amplification (MLPA).
Main Results:
- 15 out of 378 patients (3.97%) with palatal anomalies were diagnosed with 22q11.2 deletion.
- The prevalence was significantly higher (14.42%) in syndromic patients.
Conclusions:
- Submucous cleft palate (SMCP) or velopharyngeal incompetence (VPI) alongside other 22q11.2 deletion features, particularly developmental delay, may serve as effective criteria for molecular investigation.
- These findings can aid in developing targeted screening strategies for early diagnosis.
Background:
22q11.2 microdeletion syndrome is the most common multiple genetic disorder associated with learning disabilities, developmental delays, immune deficiency, hypocalcemia, and cleft palate. Finding some valid criteria for screening of 22q11.2 deletion syndromes in infants would be very helpful in early diagnosis and treatment.
Materials And Methods:
Since 69% of individuals with 22q11.2 deletion have a palatal abnormality, we studied the prevalence of 22q11.2 deletion syndrome in 378 Iranian patients during a 5-year period, including 291 patients affected with cleft palate only without cleft lip (CPO) and 87 patients affected with velopharyngeal incompetence (VPI) and/or submucous cleft palate (SMCP). DNA copy number was analyzed with multiplex ligation-dependent probe amplification (MLPA) technique.
Results:
In our study, 15/378 (3.97%) patients with palatal anomalies showed 22q11.2 deletion. Interestingly, this prevalence between syndromic patients was 15/104 (14.42%).
Conclusion:
It seems that SMCP or VPI, in addition to one or more another features of 22q11.2 deletions, especially developmental delay, may be good criteria for molecular investigation of 22q11.2 region.
More Related Videos
08:03Midface Hypoplasia and Cranial Base Morphology in Syndromic Craniosynostosis: A Comparative Analysis Study Using a Predictive Regression Model
Published on: November 4, 2025
09:16Array Comparative Genomic Hybridization Array CGH for Detection of Genomic Copy Number Variants
Published on: February 21, 2015
Related Concept Videos
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations: